<DOC>
	<DOCNO>NCT01746342</DOCNO>
	<brief_summary>Fatigue highly prevalent among multiple sclerosis ( MS ) patient pervasive adverse effect daily function quality life . The investigator find recent study obstructive sleep apnea-hypopnea ( OSAH ) common sleep abnormality multiple sclerosis ( MS ) patient . There also significant relationship OSAH high fatigue score MS patient . Preliminary work investigator group subject show treatment sleep disorder ( mostly OSAH ) improve fatigue symptom MS patient . However , necessary systemically test effect OSAH treatment randomize , control study , sure really improve fatigue symptom . The best treatment OSAH general population continuous positive airway pressure ( CPAP ) . This treatment well tolerated MS patient used device investigator ' center . This project therefore randomize , control , clinical trial CPAP MS patient OSAH . The effect six month CPAP treatment fatigue well sleep quality , somnolence , pain , disability , quality life study .</brief_summary>
	<brief_title>Sleep Apnea Multiple Sclerosis Positive Airway Pressure Trial</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Diagnosis multiple sclerosis neurologist base standard criterion ( Annals Neurol 2011 ; 69:292302 ) Expanded Disability Status Scale score 0 7.0 MSrelapse free &gt; 30 day prior screen Pittsburgh sleep quality Index &gt; 5 Fatigue Severity Scale score &gt; =4 Montreal Cognitive Assessment ( MoCA ) &gt; = 26 diagnosis OSAH polysomnography show AHI &gt; = 15 events/h sleep force vital capacity &gt; 60 % predict pregnancy plan pregnancy psychiatric condition could preclude compliance informed consent , study procedure , study requirement significant neurological , pulmonary , otorhinological , medical disorder major depression within past year value &gt; 1.5 time upper limit &lt; 0.75 low limit reference range standard clinical hemogram biochemistry determination clinically significant current treatment OSAH presence another untreated sleep disorder clinically significant severe OSAH ( safety criterion ) define AHI &gt; 30 either 4 % O2 desaturation index &gt; 15 events/h OR work safetycritical position OR ESS score &gt; =15</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>